Guanine

Product Details

CAS No:73-40-5

MF:C5H5N5O

Appearance:white or off-white crystalline powder

Specification:98.5%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Product application:Guanine, 2-Amino-1,9-dihydro-6H-purin-6-one, CAS 73-40-5, Guanine powder, High purity Guanine, Pharmaceutical grade Guanine, Feed grade Guanine, Guanine 99%, Guanine manufacturer, Guanine supplier, DNA bases, Nucleoside intermediates, Acyclovir intermediate, Valacyclovir raw material, Antiviral drug synthesis, Cosmetic pearlizing agent, Pearlescent pigment raw material, Biochemical reagent, Guanine price, Guanine export, Purine derivatives, 2-Amino-6-hydroxypurine.

Synonyms:2-AMino-6-hydroxy-1H-purine;9H-Guanine;Valaciclovir EP Impurity A;Guanine Vetec(TM) reagent grade, 99%;6H-Purin-6-one, 2-amino-1,7-dihydro- (9CI);6H-purin-6-one, 2-amino-3,7-dihydro-;Guanine (8CI);InChI=1/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11; ,Guanine,"guanine; 73-40-5; 2-Amino-6-hydroxypurine; Guanin; 2-Aminohypoxanthine; Mearlmaid; Guanine enol; Pearl essence; Stella Polaris; Dew Pearl; Naturon; Natural white 1; Natural pearl essence; 6H-Purin-6-one, 2-amino-1,7-dihydro-; CI Natural white 1; C.I. Natural White 1; Hypoxanthine, 2-amino-; 6-Hydroxy-2-aminopurine; 2-Amino-1,7-dihydro-6H-purin-6-one; 2-amino-1,7-dihydropurin-6-one; CI 75170; 2-amino-3,7-dihydropurin-6-one; C.I. 75170; CHEBI:16235; 5Z93L87A1R; C.i. no. 75170 (guanine); 2-amino-6,9-dihydro-1H-purin-6-one; DTXSID9052476; 2-amino-6,7-dihydro-3H-purin-6-one; DTXCID6031049; 200-799-8; 2-amino-1H-purin-6(7H)-one; 2-Amino-6-purinol; 2-amino-1,9-dihydro-6H-purin-6-one; 2-amino-9H-purin-6-ol; MFCD00071533; HSDB 2127; Mearlmaid AA; 6H-Purin-6-one, 2-amino-1,9-dihydro-; AI3-24393; 2-Amino-6-hydroxy-1H-purine; CHEMBL219568; 66224-64-4; 2-Amino-1,9-dihydro-purin-6-one; 71660-36-1; GUA; 2-aminohydropurin-6-one; 2-Amino-1,7-dihydro-6H-purin-6-one (Guanine); GUN; 2-amino-6-hydroxypurin; EINECS 200-799-8; 2-AMINO-3H-PURIN-6(7H)-ONE; Guanie; 6H-purin-6-one, 2-amino-3,7-dihydro-; UNII-5Z93L87A1R; 9h-guanine; 2-amino-1,9-dihydropurin-6-one; Guanine, BioUltra; Guanine (Standard); Guanine (8CI); 2-amino-6-oxypurin; 2-amino-Hypoxanthine; Guanine, 98%; GUANINE [HSDB]; GUANINE [MI]; GUANINE [USP-RS]; GUANINE [WHO-IP]; Ganciclovir EP Impurity F; bmse000090; Epitope ID:140098; SCHEMBL5259; SCHEMBL5260; Oprea1_875298; purine, 2-amino-6-hydroxy-; GUANINE [EP IMPURITY]; SCHEMBL122461; SCHEMBL142922; SCHEMBL342789; SCHEMBL443984; SCHEMBL534997; SCHEMBL535022; SCHEMBL536760; GUANINE [USP IMPURITY]; GTPL4556; orb1304746; SCHEMBL1338837; SCHEMBL1338839; SCHEMBL2216795; SCHEMBL3241710; SCHEMBL6126257; SCHEMBL7857549; 2-amino-1h-purin-6(9h)-one; SCHEMBL10332674; SCHEMBL11877187; SCHEMBL16389311; HY-Y1055R; MSK6919; ALBB-025935; BCP26793; HY-Y1055; Valacyclovir hydrochloride, guanine-; BBL009290; BBL009641; BDBM50200094; s4888; SBB004065; STK297804; STK801924; ACICLOVIR IMPURITY B [WHO-IP]; AKOS000118904; AKOS001426592; AKOS005139176; AKOS016002094; Valganciclovir hydrochloride impurity b; AC-4743; CS-6269; DB02377; FG02963; 2-amino-3,7-dihydro-6H-purin-6-one; 2-amino-6,7-dihydro-1H-purin-6-one; NCGC00246975-01; AS-10918; NCI60_012450; ST098642; ACICLOVIR IMPURITY B [EP IMPURITY]; DB-015937; G0169; GANCICLOVIR IMPURITY F [EP IMPURITY]; NS00004031; A15593; A15778; C00242; 6H-Purin-6-one, 2-amino-1,7-dihydro- (9CI); Q169313; 2-AMINO-1,7-DIHYDRO-6H-PURIN-6-ONE [WHO-IP]; F8880-3425; Z256709612; 2-Amino-1,7-dihydro-6H-purin-6-one; 2-Aminohypoxanthine; VALACICLOVIR HYDROCHLORIDE IMPURITY A [EP IMPURITY]; 3D215030-CD54-4835-A5F4-F00F86B90978; Guanine, United States Pharmacopeia (USP) Reference Standard; VALGANCICLOVIR HYDROCHLORIDE IMPURITY B [USP IMPURITY]; VALACICLOVIR HYDROCHLORIDE HYDRATE IMPURITY A [EP IMPURITY]; Guanine, Pharmaceutical Secondary Standard; Certified Reference Material; 2-Amino-6-hydroxypurine;2-Aminohypoxanthine;2-Amino-1,7-dihydro-6H-purin-6-one; InChI=1/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11",151.130,C5H5N5O,